Celldex’s Q1 Loss Widens
Celldex Therapeutics, Inc. ’s ( CLDX ) shares continued to decline after the company reported a wider-than-expected loss for the first quarter of 2014. Shares, which declined 2.4% immediately after the release of first quarter results, slipped a further 0.9% in the following trading session […]